HCM
BMY icon

Hengehold Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Hengehold Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$917K Buy
15,920
+5
+0% +$287 0.07% 110
2026
Q1 		$965K Sell
15,915
-158
-1% -$9.21K 0.08% 104
2025
Q4 		$867K Sell
16,073
-409
-2% -$19.7K 0.07% 103
2025
Q3 		$743K Buy
16,482
+150
+0.9% +$7K 0.06% 115
2025
Q2 		$756K Buy
16,332
+2
+0% +$98 0.07% 108
2025
Q1 		$996K Buy
16,330
+1
+0% +$58 0.09% 89
2024
Q4 		$924K Sell
16,329
-595
-4% -$33.2K 0.09% 91
2024
Q3 		$876K Buy
16,924
+598
+4% +$28.1K 0.08% 91
2024
Q2 		$678K Sell
16,326
-5
-0% -$224 0.07% 96
2024
Q1 		$886K Buy
16,331
+2
+0% +$102 0.09% 84
2023
Q4 		$838K Buy
16,329
+150
+0.9% +$7.87K 0.1% 81
2023
Q3 		$939K Sell
16,179
-928
-5% -$56.9K 0.12% 75
2023
Q2 		$1.09M Sell
17,107
-3,974
-19% -$266K 0.15% 68
2023
Q1 		$1.46M Sell
21,081
-33
-0.2% -$2.33K 0.2% 65
2022
Q4 		$1.52M Buy
21,114
+2
+0% +$151 0.21% 63
2022
Q3 		$1.5M Buy
21,112
+3
+0% +$218 0.23% 59
2022
Q2 		$1.63M Buy
21,109
+273
+1% +$20.8K 0.23% 57
2022
Q1 		$1.52M Sell
20,836
-129
-0.6% -$8.66K 0.21% 58
2021
Q4 		$1.31M Buy
20,965
+201
+1% +$11.8K 0.16% 63
2021
Q3 		$1.23M Buy
20,764
+119
+0.6% +$7.84K 0.16% 64
2021
Q2 		$1.38M Buy
20,645
+1
+0% +$65 0.18% 62
2021
Q1 		$1.3M Buy
20,644
+2,657
+15% +$165K 0.18% 61
2020
Q4 		$1.12M Buy
17,987
+81
+0.5% +$4.98K 0.17% 61
2020
Q3 		$1.08M Buy
17,906
+381
+2% +$22.9K 0.17% 56
2020
Q2 		$1.03M Sell
17,525
-152
-0.9% -$9.09K 0.18% 56
2020
Q1 		$985K Sell
17,677
-56
-0.3% -$3.42K 0.21% 50
2019
Q4 		$1.14M Hold
17,733
– – 0.19% 52
2019
Q3 		$899K Sell
17,733
-419
-2% -$19.7K 0.16% 55
2019
Q2 		$823K Sell
18,152
-258
-1% -$12K 0.16% 59
2019
Q1 		$878K Buy
18,410
+260
+1% +$13K 0.21% 57
2018
Q4 		$943K Buy
18,150
+154
+0.9% +$8.27K 0.3% 49
2018
Q3 		$1.12M Buy
17,996
+1
+0% +$59 0.28% 53
2018
Q2 		$996K Buy
17,995
+1
+0% +$54 0.26% 54
2018
Q1 		$1.14M Hold
17,994
– – 0.3% 55
2017
Q4 		$1.1M Buy
17,994
+1
+0% +$63 0.29% 57
2017
Q3 		$1.15M Buy
17,993
+321
+2% +$18.7K 0.3% 59
2017
Q2 		$985K Sell
17,672
-75
-0.4% -$4.08K 0.28% 61
2017
Q1 		$965K Sell
17,747
-49
-0.3% -$2.69K 0.27% 63
2016
Q4 		$1.04M Buy
17,796
+26
+0.1% +$1.42K 0.32% 59
2016
Q3 		$958K Sell
17,770
-12
-0.1% -$771 0.3% 54
2016
Q2 		$1.31M Buy
17,782
+8,055
+83% +$569K 0.43% 50
2016
Q1 		$621K Sell
9,727
-685
-7% -$43.2K 0.2% 54
2015
Q4 		$716K Hold
10,412
– – 0.26% 53
2015
Q3 		$616K Buy
10,412
+150
+1% +$9.52K 0.27% 51
2015
Q2 		$683K Sell
10,262
-500
-5% -$33K 0.24% 47
2015
Q1 		$694K Sell
10,762
-2,000
-16% -$125K 0.24% 48
2014
Q4 		$753K Sell
12,762
-155
-1% -$8.74K 0.27% 44
2014
Q3 		$661K Hold
12,917
– – 0.22% 49
2014
Q2 		$627K Sell
12,917
-363
-3% -$17.9K 0.21% 50
2014
Q1 		$690K Hold
13,280
– – 0.23% 49
2013
Q4 		$706K Buy
13,280
+518
+4% +$26.4K 0.25% 51
2013
Q3 		$591K Sell
12,762
-38,145
-75% -$1.67M 0.24% 50
2013
Q2 		$2.27M Buy
+50,907
New +$2.21M 0.98% 17

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Hengehold Capital Management's BMY Position: Q2 2026 in Review

Hengehold Capital Management increased its Bristol-Myers Squibb (BMY) stake by 0.03% in Q2 2026, buying an estimated $287 and bringing the position to 15,920 shares worth $917K. The position accounts for 0.07% of the portfolio, ranked #110.

Hengehold Capital Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.27M in Q2 2013. 938 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Hengehold Capital Management held 15,920 shares of Bristol-Myers Squibb worth $917K as of Q2 2026.
  • Hengehold Capital Management bought 5 Bristol-Myers Squibb shares in Q2 2026, an estimated $287.
  • Bristol-Myers Squibb made up 0.07% of Hengehold Capital Management's portfolio in Q2 2026, its #110 holding.
  • Hengehold Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Hengehold Capital Management's Bristol-Myers Squibb position peaked at $2.27M in Q2 2013.
  • 938 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hengehold Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.